Page 36 - Sure Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article ResearchAndMarkets.com's offering. This first edition report At-Home Testing: COVID-19 Trends and Future Potential provides an overview of trends and developments in the home testing industry for the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present - March 31, 2021. For the purpose of this report, the analyst concludes that the accepted definition of a home or self-test is on...

Intellia Therapeutics, Inc. (NASDAQ: NTLA) (before the market open) Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) (before the market open) Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) (before the market open) Insmed Incorporated (NASDAQ: INSM) (before the market open) Fulcrum Therapeutics, Inc. (NASDAQ: FULC) (before the market open) Endo International plc (NASDAQ: ENDP) (before the market open) Bio-Techne Corporation (NASDAQ: TECH) (before the market open) Harvard Bioscience, Inc. (NASDAQ: HBIO) (before the market open) Athenex, Inc. (NASDAQ: ATNX) (before the market open) Zoetis Inc. (NYS...

Points of Interest: Lufax Holding (NYSE:LU) was the largest, in terms of market cap, to set a new 52-week low. Powerbridge Technologies (NASDAQ:PBTS) is the smallest company on a market cap basis to set a new 52-week low. Relay Therapeutics (NASDAQ:RLAY) was the biggest loser, trading down 6.32% to reach its 52-week low. Here are all the stocks that set new 52-week lows as of 10 a.m. ET on Friday: Lufax Holding (NYSE:LU) shares fell to $12.25 on Friday, setting a new 52-week low with a shift of down 1.83%. Seagen (NASDAQ:SGEN) shares fell to $134.10 on Friday, setting a new 52-week low with a...

Published: Apr 29, 2021 The infectious disease in-vitro diagnostics market is prognosticated to observe promising growth across the assessment period of 2020-2030 on the back of the rising prevalence of infectious diseases around the world. The increasing incidences of infectious diseases and the growing need to tackle them at an early stage have led to tremendous advancements in terms of diagnostics. Infectious disease in-vitro diagnostics is one of them. Thus, this aspect will bring good growth opportunities for the infectious disease in-vitro diagnostics market. Infectious disease in-v...

4.2.3 Wellness Hurts 4.3 Diagnostic Technology Development1 4.3.2 NAT vs. Lateral Flow 4.3.3 The Unusual Role of GPS 4.3.4 Self and Send Competition 4.4.5 The Relationship to DTC Genetic 4.4.6 The Relationship to TeleHealth 4.4.7 Sample Collection - Who Knew? 5. OTC/DTC Infectious Disease Testing Recent Developments Recent Developments - Importance and How to Use This Section Importance of These Developments FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test Lucira Health Files for $115M IPO Spectrum Solutions Gets CE Mark ...